People experiencing a psychotic episode for the first time are less likely to receive early psychological interventions in England if they are from an ethnic minority background, finds a new study led by UCL researchers.
Nov 6, 2023
0
15
For midlife women, posttraumatic stress disorder (PTSD) symptoms are associated with higher carotid atherosclerosis and with greater brain small vessel disease and poorer cognitive performance among APOE ε4 carriers, according ...
Nov 3, 2023
0
17
New research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the early detection of skin cancer. Given that the incidence of skin cancer is on the rise, the work, ...
Nov 2, 2023
0
0
The slowdown of physical activity during adolescence is not likely caused by lifestyle and environment but by energy demands placed on the body as it grows and sexually matures, according to a new study by researchers at ...
Nov 2, 2023
0
10
The Lancet Global Health journal published two papers on October 30 showing the effectiveness and health economical impact of community-based intervention for household child contact management. Led by the French National ...
Oct 31, 2023
0
0
Psychotic disorders affect around one in 100 people globally and are among the most severe mental health problems.
Oct 23, 2023
0
2
Postpartum depression can affect anyone, and it often sneaks in quietly, like a shadow in the corners of a new mother's life. It presents significant challenges for around 1 in 7 new mothers, affecting their emotional well-being ...
Oct 20, 2023
0
0
The final Curtin University-led After the Fires report has highlighted the mental health struggles of first responders in the aftermath of the devastating Black Summer Bushfires. The study found that reducing stigma associated ...
Oct 18, 2023
0
0
Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people. The trial's results, ...
Oct 11, 2023
0
21
A three-year clinical trial has shown that the sublingual immunotherapy, or SLIT, is safe in peanut-allergic children ages 1 to 4, with a greater likelihood of desensitization and remission the earlier the treatment began.
Oct 10, 2023
0
2
